It is a proud moment for us to receive validation once again from our most important stakeholders – our employees. This recognition continues to provide valuable ... Apr 26
Joint Venture Partnership Expansion in Guntur, AP... Jan 09
Situated in a district where public health resources are limited, a small village near Thane has stood out for its remarkable achievement. Within the 30 ... Aug 26
Recently, a fresh new case of avian influenza has been seen in the Bokaro district of Jharkhand. The government is on alert after 400 chickens ... Feb 24
Sadness, feeling down and having a loss of interest or pleasure in daily activities are familiar feelings for all of us. But if they persist ... Jun 22
Tel Aviv University researchers have published a new study in Nature outlining how a type of white blood cell can be engineered to secrete anti-... Jun 15
Despite agriculture being the prime occupation for 58% of Indians, around one-fifth of farmers hold less than 0.01 hectares of land. Read to ... Apr 14
Latest pharma news update... Nov 03
Latest FDA drug approval update... Jun 24
People should be able to avail the facilities under the scheme without having to travel far. This is possible if maximum number of hospitals get ... Apr 12
Forge Biologics receives FDA fast track, orphan drug, and rare pediatric disease designations for FBX-101 gene therapy for patients with krabbe disease ... Feb 17
The acquisition will establish a new modality for drug discovery and development at Lilly ... Dec 15
UX701 is currently in late preclinical development, and an investigational new drug (IND) application is expected to be filed with the US FDA by the ... Dec 11
Shape Therapeutics, announces today the unveiling of the AAVidTM capsid discovery platform and results from its first AAV5 variant library in a non-human primate ... Dec 04
AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
... Nov 06
LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) ... Nov 04
... Oct 30
Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19... Oct 28
Leigh syndrome is characterized by progressive loss of mental and movement abilities that can result in death within two to three years... Oct 28
... Oct 28
... Oct 27
Selecta Biosciences and AskBio receives US FDA rare pediatric disease designation for their gene therapy for methylmalonic acidemia ... Oct 21
This new partnership represents Dyno’s largest collaboration to date and this will expand the frontier of gene therapies for the central nervous system and ... Oct 15
Manufacturing agreement for Autologous T-Cell Receptor-Based Cell Therapy... Sep 24
-Advertisements-
Wednesday, May 01, 2024
.jpeg)
.jpg)
